Pacer Advisors
GMAB icon

Pacer Advisors’s Genmab GMAB Stock Holding History

Pacer Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,810
Closed -$221K – 2635
2023
Q2 		$221K Buy
5,810
+740
+15% +$29.5K ﹤0.01% 1886
2023
Q1 		$191K Buy
5,070
+162
+3% +$6.23K ﹤0.01% 1397
2022
Q4 		$208K Buy
+4,908
New +$202K ﹤0.01% 2140
2022
Q1 		– Sell
-5,084
Closed -$201K – 2386
2021
Q4 		$201K Sell
5,084
-182
-3% -$7.59K ﹤0.01% 2053
2021
Q3 		$230K Buy
5,266
+162
+3% +$7.27K ﹤0.01% 1309
2021
Q2 		$208K Hold
5,104
– – ﹤0.01% 1288
2021
Q1 		$168K Sell
5,104
-270
-5% -$10.2K ﹤0.01% 1278
2020
Q4 		$219K Sell
5,374
-1,188
-18% -$44.4K ﹤0.01% 1228
2020
Q3 		$240K Buy
+6,562
New +$237K 0.01% 1160

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Pacer Advisors's GMAB Position: Q3 2023 in Review

Pacer Advisors sold out of Genmab (GMAB) in Q3 2023, closing a stake of 5,810 shares — an estimated $221K sold.

Pacer Advisors first reported a position in GMAB in Q3 2020 and held it in 9 quarters. The position peaked at $240K in Q3 2020. 233 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.

  • Pacer Advisors reported no remaining Genmab position as of Q3 2023 after selling out during the quarter.
  • Pacer Advisors sold 5,810 Genmab shares in Q3 2023, an estimated $221K.
  • Pacer Advisors first reported a position in Genmab in Q3 2020 and held it in 9 quarters.
  • Pacer Advisors's Genmab position peaked at $240K in Q3 2020.
  • 233 funds tracked by Wall St. Rank held Genmab as of Q3 2023.

Based on Pacer Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.